文献速递儿童青少年精神

Wnt1内含子1新突变导致中脑多巴胺能神经元发育缺失与大鼠孤独症样行为

A novel mutation in intron 1 of Wnt1 causes developmental loss of dopaminergic neurons in midbrain and ASD-like behaviors in rats.
PubMed 文献 · Mol Psychiatry · 2023-09-01

该研究在大规模孤独症谱系障碍(ASD)风险/致病基因筛选中发现Wnt1内含子1的纯合突变,该突变在内含子1中产生新的剪接供体位点并导致WNT1表达下降。携带该突变的人源化大鼠模型表现出孤独症样行为,中脑黑质致密部(SNpc)与腹侧被盖区(VTA)多巴胺能神经元显著丢失,左旋多巴治疗可几乎完全改善超声发声与社交互动损害,但不改善受限重复行为。

要点

  • Wnt1内含子1纯合突变产生新剪接供体位点,导致WNT1表达下降。
  • 突变大鼠中脑多巴胺能神经元及纹状体多巴胺能纤维显著减少。
  • 左旋多巴可改善突变大鼠的超声发声与社交互动,但不改善受限重复行为。

核心结论

  • Wnt1内含子1突变所致中脑多巴胺能神经元发育性丢失是ASD样行为的病理基础,异常祖细胞图式化是该丢失的细胞学基础。
  • 多巴胺治疗对ASD样行为部分有效,提示转化意义。

研究设计与样本

  • 研究对大样本进行ASD风险/致病基因大规模筛选,鉴定出Wnt1内含子1的纯合突变。
  • 构建携带该突变的人源化大鼠模型,并进行行为学、组织学与单细胞RNA测序分析。
  • 对突变大鼠进行左旋多巴治疗实验以评估行为改善。

主要发现

  • 突变大鼠表现超声发声(USV)受损、社交互动减少及受限重复行为等ASD样行为。
  • 突变大鼠SNpc与VTA多巴胺能神经元显著丢失,纹状体多巴胺能纤维相应减少。
  • 单细胞RNA测序提示中脑多巴胺能神经元减少可能与胚胎早期祖细胞池边界从下丘脑底板向中脑底板移位有关。
  • 左旋多巴治疗几乎完全减轻USV受损与社交互动障碍,但未改善受限重复行为。

临床怎么用

  • 对ASD患者可关注Wnt1等相关基因的剪接位点突变筛查价值。
  • 多巴胺能系统可能作为ASD部分症状(社交与发声)的干预靶点,但受限重复行为需另行干预。

局限性

  • 研究基于大鼠模型,结论向人类临床转化仍需进一步验证。
  • 左旋多巴仅改善部分ASD样行为,对受限重复行为无效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders with a strong genetic liability. Despite extensive studies, however, the underlying pathogenic mechanism still remains elusive. In the present study, we identified a homozygous mutation in the intron 1 of Wnt1 via large-scale screening of ASD risk/causative genes and verified that this mutation created a new splicing donor site in the intron 1, and consequently, a decrease of WNT1 expression. Interestingly, humanized rat models harboring this mutation exhibited robust ASD-like behaviors including impaired ultrasonic vocalization (USV), decreased social interactions, and restricted and repetitive behaviors. Moreover, in the substantia nigra compacta (SNpc) and the ventral tegmental area (VTA) of mutant rats, dopaminergic (DAergic) neurons were dramatically lost, together with a comparable decrease in striatal DAergic fibers. Furthermore, using single-cell RNA sequencing, we demonstrated that the decreased DAergic neurons in these midbrain areas might attribute to a shift of the boundary of the local pool of progenitor cells from the hypothalamic floor plate to the midbrain floor plate during the early embryonic stage. Moreover, treatments of mutant rats with levodopa could attenuate the impaired USV and social interactions almost completely, but not the restricted and repetitive behaviors. Our results for the first time documented that the developmental loss of DAergic neurons in the midbrain underlies the pathogenesis of ASD, and that the abnormal progenitor cell patterning is a cellular underpinning for this developmental DAergic neuronal loss. Importantly, the effective dopamine therapy suggests a translational significance in the treatment of ASD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Li Y, Zhu M, Chen WX, et al. A novel mutation in intron 1 of Wnt1 causes developmental loss of dopaminergic neurons in midbrain and ASD-like behaviors in rats. Mol Psychiatry. 2023. PMID: 37658228. doi:10.1038/s41380-023-02223-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。